12 results
DRS/A
EX-10.16
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
14 Oct 20
Draft registration statement (amended)
12:00am
) as a hazardous substance, hazardous waste, hazardous material, pollutant or contaminant, (b) a petroleum hydrocarbon, including crude oil or any fraction
S-1
EX-10.16
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
29 Oct 20
IPO registration
5:04pm
) as a hazardous substance, hazardous waste, hazardous material, pollutant or contaminant, (b) a petroleum hydrocarbon, including crude oil or any fraction
S-1/A
EX-10.26
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
9 Nov 20
IPO registration (amended)
2:05pm
”, “pollutant”, “contaminant”, “waste”, “irritant”, “corrosive”, “flammable”, “radioactive”, “reactive”, “carcinogenic”, “mutagenic”, “bioaccumulative
10-K
2020 FY
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
22 Mar 21
Annual report
4:22pm
Technologies product categories include HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents and custom services … % of our Biologics Safety Testing revenue in the year ended December 31, 2020.
Other impurity and contaminant kits. Products in this category include
DRS/A
k0cwy4wtpcatv0
23 Oct 20
Draft registration statement (amended)
12:00am
424B4
4eqdv4mvmw vvn
23 Nov 20
Prospectus supplement with pricing info
4:36pm
DRS
2mtb1l 6wfjets
8 Sep 20
Draft registration statement
12:00am
DRS/A
6g8t0 4abd
14 Oct 20
Draft registration statement (amended)
12:00am
S-1
qg5u5kc
29 Oct 20
IPO registration
5:04pm
8-K
EX-2.1
m34mimn
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
- Prev
- 1
- Next